Pglyrp1 has a pro-inflammatory effect in three mouse models of inflammatory skin diseases (psoriasis, atopic dermatitis, and contact dermatitis) [16, 17] and in experimentally induced asthma [18], but has anti-inflammatory effect in experimentally induced arthritis [15]. Here, PGLYRP1 is linked to arthritic joint disease.